Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia

Decreased plasma levels of gasotransmitter hydrogen sulfide in patients with schizophrenia: correlation with psychopathology and cognition

(2018) Jian-wen Xiong et al.   PSYCHOPHARMACOLOGY

Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia

(2016) Yuan-Jian Yang et al.   PSYCHIATRY RESEARCH

MK-801-induced deficits in social recognition in rats

(2015) Serena Deiana et al.   BEHAVIOURAL PHARMACOLOGY

Antipsychotic medication in schizophrenia: a review

(2015) John Lally et al.   BRITISH MEDICAL BULLETIN

The role of nitric oxide donors in schizophrenia: Basic studies and clinical applications

(2015) Nikolaos Pitsikas   EUROPEAN JOURNAL OF PHARMACOLOGY

The Early Longitudinal Course of Cognitive Deficits in Schizophrenia

(2014) Keith H. Nuechterlein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: A controlled study

(2014) Serkan Zincir et al.   PSYCHIATRY RESEARCH

Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments

(2014) Chen Zhang et al.   SCHIZOPHRENIA RESEARCH

Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia

(2014) Xiaofeng Guo et al.   SCHIZOPHRENIA RESEARCH

Comparision of Effects of Rosuvastatin Versus Atorvastatin Treatment on Plasma Levels of Asymmetric Dimethylarginine in Patients With Hyperlipidemia Having Coronary Artery Disease

(2013) Ertugrul Kurtoglu et al.   ANGIOLOGY

Asymmetric Dimethylarginine: A Possible Link between Vascular Disease and Dementia

(2013) Muhammad Asif et al.   Current Alzheimer Research

Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice

(2013) Ana C. Issy et al.   PSYCHOPHARMACOLOGY

Remission in Schizophrenia: Critical and Systematic Review

(2013) Bandar AlAqeel et al.   HARVARD REVIEW OF PSYCHIATRY

Arginine and Asymmetric Dimethylarginine in Puromycin Aminonucleoside-Induced Chronic Kidney Disease in the Rat

(2011) Gin-Fu Chen et al.   AMERICAN JOURNAL OF NEPHROLOGY

Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis

(2011) Ricardo E. Carrión et al.   AMERICAN JOURNAL OF PSYCHIATRY

Asymmetric Dimethylarginine Is Increased in Asthma

(2011) Jeremy A. Scott et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome

(2011) Iván Palomo et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia

(2011) Cemil Celik et al.   PSYCHIATRY RESEARCH

What Do We Know About Neuropsychological Aspects Of Schizophrenia?

(2009) Barton W. Palmer et al.   NEUROPSYCHOLOGY REVIEW

Atypical Antipsychotics, Neurocognitive Deficits, and Aggression in Schizophrenic Patients

(2008) Menahem I. Krakowski et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Subchronic MK-801 behavioural deficits in rats: Partial reversal by the novel nitrate GT 1061

(2008) Richard J. Beninger et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls

(2008) Bun-Hee Lee et al.   SCHIZOPHRENIA RESEARCH

General and social cognition in first episode schizophrenia: Identification of separable factors and prediction of functional outcome using the IntegNeuro test battery

(2007) Leanne M. Williams et al.   SCHIZOPHRENIA RESEARCH